首页>
外国专利>
Pharmaceutical combination of telmisartan and atorvastatin for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal disease
Pharmaceutical combination of telmisartan and atorvastatin for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal disease
展开▼
机译:替米沙坦与阿托伐他汀的药物组合可预防或治疗心血管,心肺,肺或肾脏疾病
展开▼
页面导航
摘要
著录项
相似文献
摘要
The use of the angiotensin II receptor antagonist telmisartan (I) (or its salt) and the 3-hydroxy-2-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor atorvastatin (II) is claimed in the production of medicaments (A) for the treatment or prophylaxis of cardiovascular, cardiopulmonary or renal diseases in humans or other mammals. Independent claims are included for corresponding treatment methods and pharmaceutical compositions. ACTIVITY : Cardiant; Vasotropic; Hepatotropic; Hypotensive; Antilipemic; Antiarteriosclerotic; Antiasthmatic; Antiinflammatory; Antidiabetic; Cerebroprotective; Antianginal; Cytostatic; Antibacterial; Immunosuppressive; Vulnerary; Osteopathic; Neuroprotective; Nootropic. MECHANISM OF ACTION : Angiotensin II receptor antagonist; HMG-CoA reductase inhibitor; Peroxisome proliferator activated receptor-gamma (PPAR-gamma ) regulating gene expression inducer; Matrix metalloproteinase MMP-9 expression controller; Cytokine CD40L antagonist.
展开▼